Literature DB >> 35734007

Evaluating the impact of Xpert® MTB/RIF on mortality from TB: are we asking the right questions?

K Chani1,2, M P Sekadde3, R A Dlodlo4, S M Graham2,5.   

Abstract

Entities:  

Year:  2022        PMID: 35734007      PMCID: PMC9176194          DOI: 10.5588/pha.22.0021

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


× No keyword cloud information.
  9 in total

1.  Sputum smear microscopy in the Xpert® MTB/RIF era.

Authors:  A Van Deun; S Tahseen; D Affolabi; M A Hossain; M L Joloba; P K Angra; J C Ridderhof; B C de Jong; H L Rieder
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-19       Impact factor: 2.373

2.  Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.

Authors:  T Agizew; R Boyd; A F Auld; L Payton; S L Pals; P Lekone; V Chihota; A Finlay
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

3.  Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis.

Authors:  Kamila Romanowski; Brett Baumann; C Andrew Basham; Faiz Ahmad Khan; Greg J Fox; James C Johnston
Journal:  Lancet Infect Dis       Date:  2019-07-16       Impact factor: 25.071

4.  Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.

Authors:  Gavin J Churchyard; Wendy S Stevens; Lerole D Mametja; Kerrigan M McCarthy; Violet Chihota; Mark P Nicol; Linda K Erasmus; Norbert O Ndjeka; Lindiwe Mvusi; Anna Vassall; Edina Sinanovic; Helen S Cox; Christopher Dye; Alison D Grant; Katherine L Fielding
Journal:  Lancet Glob Health       Date:  2015-08       Impact factor: 26.763

Review 5.  Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review.

Authors:  Edine W Tiemersma; Marieke J van der Werf; Martien W Borgdorff; Brian G Williams; Nico J D Nagelkerke
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

6.  Tuberculosis related disability: a systematic review and meta-analysis.

Authors:  Kefyalew Addis Alene; Kinley Wangdi; Samantha Colquhoun; Kudakwashe Chani; Tauhid Islam; Kalpeshsinh Rahevar; Fukushi Morishita; Anthony Byrne; Justin Clark; Kerri Viney
Journal:  BMC Med       Date:  2021-09-09       Impact factor: 8.775

7.  Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.

Authors:  Frederick Haraka; Mwaka Kakolwa; Samuel G Schumacher; Ruvandhi R Nathavitharana; Claudia M Denkinger; Sebastien Gagneux; Klaus Reither; Amanda Ross
Journal:  Cochrane Database Syst Rev       Date:  2021-05-06

8.  Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.

Authors:  Gian Luca Di Tanna; Ali Raza Khaki; Grant Theron; Kerrigan McCarthy; Helen Cox; Lucy Mupfumi; Anete Trajman; Lynn Sodai Zijenah; Peter Mason; Tsitsi Bandason; Betina Durovni; Wilbert Bara; Michael Hoelscher; Petra Clowes; Chacha Mangu; Duncan Chanda; Alexander Pym; Peter Mwaba; Frank Cobelens; Mark P Nicol; Keertan Dheda; Gavin Churchyard; Katherine Fielding; John Z Metcalfe
Journal:  Lancet Glob Health       Date:  2019-02       Impact factor: 26.763

9.  Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial.

Authors:  Andrew F Auld; Tefera Agizew; Anikie Mathoma; Rosanna Boyd; Anand Date; Sherri L Pals; Christopher Serumola; Unami Mathebula; Heather Alexander; Tedd V Ellerbrock; Goabaone Rankgoane-Pono; Pontsho Pono; James C Shepherd; Katherine Fielding; Alison D Grant; Alyssa Finlay
Journal:  BMC Med       Date:  2020-02-11       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.